TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
UCB Pharma Oy Finland
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
18,041
|
17,536
|
17,560 |
| Financial expenses |
45
|
35
|
26 |
| Earnings before taxes |
788
|
465
|
640 |
| Total assets |
8,150
|
7,557
|
6,305 |
| Current assets |
1,216
|
1,565
|
324 |
| Current liabilities |
4,651
|
3,524
|
5,644 |
| Equity capital |
813
|
547
|
660 |
| - share capital |
8
|
8
|
8 |
| Employees (average) |
14
|
16
|
18 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
10.0%
|
7.2%
|
10.5% |
| Turnover per employee |
1,289
|
1,096
|
976 |
| Profit as a percentage of turnover |
4.4%
|
2.7%
|
3.6% |
| Return on assets (ROA) |
10.2%
|
6.6%
|
10.6% |
| Current ratio |
26.1%
|
44.4%
|
5.7% |
| Return on equity (ROE) |
96.9%
|
85.0%
|
97.0% |
| Change turnover |
505
|
-24
|
660 |
| Change turnover % |
3%
|
0%
|
4% |
| Chg. No. of employees |
-2
|
-2
|
-1 |
| Chg. No. of employees % |
-13%
|
-11%
|
-5% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.